Cargando…

Penetration Enhancers in Ocular Drug Delivery

There are more than 100 recognized disorders of the eye. This makes the development of advanced ocular formulations an important topic in pharmaceutical science. One of the ways to improve drug delivery to the eye is the use of penetration enhancers. These are defined as compounds capable of enhanci...

Descripción completa

Detalles Bibliográficos
Autores principales: Moiseev, Roman V., Morrison, Peter W. J., Steele, Fraser, Khutoryanskiy, Vitaliy V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681039/
https://www.ncbi.nlm.nih.gov/pubmed/31324063
http://dx.doi.org/10.3390/pharmaceutics11070321
_version_ 1783441640618196992
author Moiseev, Roman V.
Morrison, Peter W. J.
Steele, Fraser
Khutoryanskiy, Vitaliy V.
author_facet Moiseev, Roman V.
Morrison, Peter W. J.
Steele, Fraser
Khutoryanskiy, Vitaliy V.
author_sort Moiseev, Roman V.
collection PubMed
description There are more than 100 recognized disorders of the eye. This makes the development of advanced ocular formulations an important topic in pharmaceutical science. One of the ways to improve drug delivery to the eye is the use of penetration enhancers. These are defined as compounds capable of enhancing drug permeability across ocular membranes. This review paper provides an overview of anatomical and physiological features of the eye and discusses some common ophthalmological conditions and permeability of ocular membranes. The review also presents the analysis of literature on the use of penetration-enhancing compounds (cyclodextrins, chelating agents, crown ethers, bile acids and bile salts, cell-penetrating peptides, and other amphiphilic compounds) in ocular drug delivery, describing their properties and modes of action.
format Online
Article
Text
id pubmed-6681039
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-66810392019-08-09 Penetration Enhancers in Ocular Drug Delivery Moiseev, Roman V. Morrison, Peter W. J. Steele, Fraser Khutoryanskiy, Vitaliy V. Pharmaceutics Review There are more than 100 recognized disorders of the eye. This makes the development of advanced ocular formulations an important topic in pharmaceutical science. One of the ways to improve drug delivery to the eye is the use of penetration enhancers. These are defined as compounds capable of enhancing drug permeability across ocular membranes. This review paper provides an overview of anatomical and physiological features of the eye and discusses some common ophthalmological conditions and permeability of ocular membranes. The review also presents the analysis of literature on the use of penetration-enhancing compounds (cyclodextrins, chelating agents, crown ethers, bile acids and bile salts, cell-penetrating peptides, and other amphiphilic compounds) in ocular drug delivery, describing their properties and modes of action. MDPI 2019-07-09 /pmc/articles/PMC6681039/ /pubmed/31324063 http://dx.doi.org/10.3390/pharmaceutics11070321 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Moiseev, Roman V.
Morrison, Peter W. J.
Steele, Fraser
Khutoryanskiy, Vitaliy V.
Penetration Enhancers in Ocular Drug Delivery
title Penetration Enhancers in Ocular Drug Delivery
title_full Penetration Enhancers in Ocular Drug Delivery
title_fullStr Penetration Enhancers in Ocular Drug Delivery
title_full_unstemmed Penetration Enhancers in Ocular Drug Delivery
title_short Penetration Enhancers in Ocular Drug Delivery
title_sort penetration enhancers in ocular drug delivery
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681039/
https://www.ncbi.nlm.nih.gov/pubmed/31324063
http://dx.doi.org/10.3390/pharmaceutics11070321
work_keys_str_mv AT moiseevromanv penetrationenhancersinoculardrugdelivery
AT morrisonpeterwj penetrationenhancersinoculardrugdelivery
AT steelefraser penetrationenhancersinoculardrugdelivery
AT khutoryanskiyvitaliyv penetrationenhancersinoculardrugdelivery